Botanical guide · Ingredient reference

Reishi and sleep in mice: a drug-induced model is not a human insomnia trial

A laboratory study connected a reishi-derived preparation with sleep measures and gut-microbiota changes in mice. Human clinical benefit was not tested.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What was tested

Researchers administered the acidic fraction of an alcohol extract of reishi mycelia for 28 days. Sleep latency and duration were measured in a pentobarbital-induced sleep model. [1]

The preparation shortened latency and lengthened sleep in that setting. Serotonin-related measures and gut microbial metabolites changed, while antibiotic depletion of gut microbiota removed the reported sleep-promoting effect. [1]

How far the result applies

These observations support a mechanistic hypothesis in this experimental system. They do not establish that a reishi tea treats human insomnia, or supply a human dose. Animal drug-induced sleep differs from ordinary human sleep. The authors declared no competing interests; funding was not established from the retrieved record. [1]

A hypothetical reading of the evidence

Imagine a compound changes an animal’s response to a sedative. That result still requires separate testing for a human sleep complaint.

Interpretation checklist — Reishi and sleep in mice
DetailInterpretation
Study resultLimited to its measured outcomes
Other preparationEquivalence not established
Broader claimNeeds separate evidence
Reishi and sleep in mice: a drug-induced model is not a human insomnia trial — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Ganoderma lucidum promotes sleep through a gut microbiota-dependent and serotonin-involved pathway in mice - PubMed
    Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.